Celularity Inc Balance Sheet
CELU|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Celularity Inc had $107M in total assets with negative shareholders' equity of $38M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $6.2M | $738.0K | $227.0K | $14.0M | $37.2M |
| Inventory | $571.0K | $5.4M | $5.8M | $5.3M | $9.5M |
| Current Assets | $12.3M | $20.6M | $19.8M | $33.5M | $59.1M |
| PP&E (Net) | $55.8M | $61.6M | $67.8M | $75.7M | $90.6M |
| Goodwill | $7.3M | $7.3M | $7.3M | $119.7M | $123.3M |
| Total Assets | $107.3M | $132.7M | $143.9M | $401.1M | $414.1M |
| Current Liabilities | $80.8M | $53.7M | $67.3M | $62.1M | $26.2M |
| Shareholders' Equity | -$38.1M | $8.8M | $41.0M | $198.9M | $99.4M |